Evidence map›Paper›PMID 16478988›Full record

ArticleMolecular and cellular biology2006

Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation.

Xiaohua Su, Vidya Gopalakrishnan, Duncan Stearns, Kenneth Aldape, Fredrick F Lang, Gregory Fuller, Evan Snyder, Charles G Eberhart, Sadhan Majumder

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 146 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. REST in the Road Map of Brain Development.Cellular and molecular neurobiology · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Homeostatic Plasticity in Epilepsy.Frontiers in cellular neuroscience · 2020
    Article
  14. The Non-coding Side of Medulloblastoma.Frontiers in cell and developmental biology · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiaohua SuDepartment of Molecular Genetics, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Mail 1006, Room S13.8136C, Houston, TX 77030, USA.
Vidya Gopalakrishnan
Duncan Stearns
Kenneth Aldape
Fredrick F Lang
Gregory Fuller
Evan Snyder
Charles G Eberhart
Sadhan Majumder
The University of Texas MD Anderson Cancer Center · USJohns Hopkins Medicine · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
TRANSCRIPTION FACTOR REST/NRSF IN MEDULLOBLASTOMAR01CA081255 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MAJUMDER, SADHAN · 1999 to 2010
$2.1M
Myc Signaling in MedulloblastomasK08NS043279 · NINDS · JOHNS HOPKINS UNIVERSITY · PI EBERHART, CHARLES GEORGE · 2002 to 2006
$862k
NCI NIH HHS CA16672NCI NIH HHS CA 81255NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA081255NINDS NIH HHS K08 NS043279NINDS NIH HHS K08NS43279
6 · The paper itself

Abstract

Medulloblastoma, one of the most malignant brain tumors in children, is thought to arise from undifferentiated neural stem/progenitor cells (NSCs) present in the external granule layer of the cerebellum. However, the mechanism of tumorigenesis remains unknown for the majority of medulloblastomas. In this study, we found that many human medulloblastomas express significantly elevated levels of both myc oncogenes, regulators of neural progenitor proliferation, and REST/NRSF, a transcriptional repressor of neuronal differentiation genes. Previous studies have shown that neither c-Myc nor REST/NRSF alone could cause tumor formation. To determine whether c-Myc and REST/NRSF act together to cause medulloblastomas, we used a previously established cell line derived from external granule layer stem cells transduced with activated c-myc (NSC-M). These immortalized NSCs were able to differentiate into neurons in vitro. In contrast, when the cells were engineered to express a doxycycline-regulated REST/NRSF transgene (NSC-M-R), they no longer underwent terminal neuronal differentiation in vitro. When injected into intracranial locations in mice, the NSC-M cells did not form tumors either in the cerebellum or in the cerebral cortex. In contrast, the NSC-M-R cells did produce tumors in the cerebellum, the site of human medulloblastoma formation, but not when injected into the cerebral cortex. Furthermore, the NSC-M-R tumors were blocked from terminal neuronal differentiation. In addition, countering REST/NRSF function blocked the tumorigenic potential of NSC-M-R cells. To our knowledge, this is the first study in which abnormal expression of a sequence-specific DNA-binding transcriptional repressor has been shown to contribute directly to brain tumor formation. Our findings indicate that abnormal expression of REST/NRSF and Myc in NSCs causes cerebellum-specific tumors by blocking neuronal differentiation and thus maintaining the "stemness" of these cells. Furthermore, these results suggest that such a mechanism plays a role in the formation of human medulloblastoma.

Indexed as

Genes, mycAdolescentAdultAnimalsCarcinogenicity TestsCell DifferentiationCerebellar NeoplasmsChildChild, PreschoolDoxycyclineGene Expression Regulation, NeoplasticHumansMedulloblastomaMiceMice, NudeNeuronsDoxycyclineRE1-Silencing Transcription FactorRecombinant ProteinsRepressor ProteinsTranscription Factors

Identifiers

PMID16478988
PMCPMC1430235
OpenAlexW2117293998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.